130 abstracts found.



Chromosome breakage and inheritable cancers

Year:

Session type:

Theme:

Stephen West1
1The Francis Crick Institute

Learning from research on cancer disparities in the US

Year:

Session type:

Theme:

Nancy Keating1
1Harvard Medical School

Pre-clinical models of glioblastoma that enable more accurate evaluation of new treatment combinations

Year:

Session type:

Theme:

Anthony Chalmers1
1Glasgow Centre for Cancer Research

People Like You: Genomics in a London breast cancer service

Year:

Session type:

Theme:

Sophie Day1
1Goldsmiths University, London

Cell function and tumor formation

Year:

Session type:

Theme:

Stefano Piccolo1
1University of Padua

Social inequalities in cancer screening participation

Year:

Session type:

Theme:

Jo Waller1
1University College London

Why is cancer so difficult?

Year:

Session type:

Theme:

Martin Christlieb1
1University of Oxford

Myeloid cells in the ovarian cancer microenvironment

Year:

Session type:

Theme:

Fran Balkwill1
1Barts Cancer Institute

Inflammation driven cancer: Genes, cells and microbes

Year:

Session type:

Theme:

Fiona Powrie1
1Kennedy Institute of Rheumatology, University of Oxford

The role of individual and system factors on inequalities in cancer care and outcomes

Year:

Session type:

Theme:

Bernard Rachet1
1London School of Hygiene and Tropical Medicine

De-mystifying today’s science

Year:

Session type:

Theme:

Elaine Vickers1
1Science Communicated

Macrophages: Bad Actors in Cancer

Year:

Session type:

Theme:

Jeffrey Pollard1
1The University of Edinburgh

Evolutionary dynamics of cancer subclones

Year:

Session type:

Theme:

Trevor Graham1
1Barts Cancer Institute

Tumour microenvironment and radiation – friend or foe?

Year:

Session type:

Theme:

Kaye Williams1
1University of Manchester

Why is behaviour change so difficult?

Year:

Session type:

Theme:

Theresa Marteau1
1University of Cambridge

Early pancreatic cancer diagnostics

Year:

Session type:

Theme:

Stephen Pereira1
1University College London

Targeting the DNA Damage Response with a Selective CHK1 Inhibitor

Year:

Session type:

Theme:

Ian Collins1
1The Institute of Cancer Research

DNA damage repair inhibitors and radiation- are normal tissues spared?

Year:

Session type:

Theme:

Susan Short1
1University of Leeds

Advances in the measurement of patient-reported outcomes

Year:

Session type:

Theme:

John Ware1
1University of Massachusetts Medical School

Web-based system to monitor cancer patients’ physical symptoms during active treatment-engaging patients and clinicians

Year:

Session type:

Theme:

Galina Velikova1
1University of Leeds

Patient-reported outcomes for adverse event and symptom monitoring in oncology

Year:

Session type:

Theme:

Ethan Basch1
1University of North Carolina at Chapel Hill

Challenges and opportunities for quality of life and symptom assessment in cancer clinical trials

Year:

Session type:

Theme:

Melanie Calvert1
1University of Birmingham

EORTC Perspectives on QOL in clinical trials

Year:

Session type:

Theme:

Andrew Bottomley1
1EORTC

WNT signalling and the Mediator complex associated kinases CDK8/19

Year:

Session type:

Theme:

Julian Blagg1
1The Institute of Cancer Research

Different smoking cessation options and their effectiveness, including Stop Smoking Services and e-cigarettes

Year:

Session type:

Theme:

Leonie Brose1
1King's College London

Epidemiological research showing that tobacco use is the largest preventable cause of cancer – including types of cancer beyond just lung cancer

Year:

Session type:

Theme:

Kamran Siddiqi1
1University of York

From CRISPR-Cas9 drop-out screens to novel therapeutic approaches in acute myeloid leukaemia

Year:

Session type:

Theme:

George Vassiliou1
1Wellcome Trust Sanger Institute

Modelling cancer in human stem cell organoid cultures

Year:

Session type:

Theme:

Jarno Drost1
1Princess Máxima Centre for Paediatric Oncology

Heterocellular interaction in the tumour microenvironment

Year:

Session type:

Theme:

Claus Jorgensen1
1CRUK Manchester Institute

Antigen discovery in long term pancreatic cancer survivors

Year:

Session type:

Theme:

Vinod Balachandran1
1Memorial Sloan-Kettering Cancer Center

Care of dying people: Why, how and what?

Year:

Session type:

Theme:

Bee Wee1
1University of Oxford

Innovations in AYA Care from North America

Year:

Session type:

Theme:

Rebecca Johnson1
1Mary Bridge Hospital, Tacoma, Washington

CART cell immunotherapy for lymphoma

Year:

Session type:

Theme:

Karl Peggs1
1UCL Cancer Institute

Introducing targeted therapies into lymphoma management

Year:

Session type:

Theme:

Graham Collins1
1Oxford University Hospitals NHS Foundation Trust

Targeting stem cells in colorectal cancer

Year:

Session type:

Theme:

Felipe de Sousa e Melo1
1Roche

Functional Magnetic Resonance Imaging (MRI) for assessing response to Radiotherapy

Year:

Session type:

Theme:

Nandita deSouza1
1The Institute of Cancer Research

1.5T MRI-linac: bringing sight to the radiotherapy treatment

Year:

Session type:

Theme:

Bas Raaymakers1
1UMC Utrecht

Mechanical guidance of collective cell invasion

Year:

Session type:

Theme:

Xavier Trepat1
1Institute for Bioengineering of Catalonia

Carcinoma-associated fibroblasts exert mechanical forces on the basement membrane to help cancer cell invasion

Year:

Session type:

Theme:

Danijela Matic Vignjevic1
1Institut Curie

Vitamin D and colon cancer survival: What can we learn from MPE studies?

Year:

Session type:

Theme:

Helen Coleman1
1Queen's University Belfast

Molecular pathological epidemiology of colorectal cancer in the Netherlands Cohort Study and Rainbow-TMA

Year:

Session type:

Theme:

Piet van den Brandt1
1Maastricht University

Emerging topics in MPE: Integration of immunology and microbiology

Year:

Session type:

Theme:

Shuji Ogino1
1Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health

The use of tool compounds to validate and invalidate oncology targets

Year:

Session type:

Theme:

Nicola Wallis1
1Astex Therapeutics

The clinical applications of multi-parametric MRI for radiotherapy planning and treatment

Year:

Session type:

Theme:

Roberto Alonzi1
1Mount Vernon Cancer Centre

Stromal/leukocyte crosstalk in immunity and tumour progression

Year:

Session type:

Theme:

Sophie Acton1
1University College London

PARP inhibitor resistance and acquired vulnerability in ovarian cancer

Year:

Session type:

Theme:

Alan D'Andrea1
1Dana-Farber Cancer Institute

Phosphorylation-dependent assembly of DNA damage response complexes

Year:

Session type:

Theme:

Laurence Pearl1
1University of Sussex

The clinical use of protons in UK: Establishing an evidence based framework

Year:

Session type:

Theme:

Adrian Crellin1
1NIHR Cancer Research Network (NCRN)

Selection of patients for clinical trials in proton therapy – the model-based approach

Year:

Session type:

Theme:

Cai Grau1
1Danish Centre for Particle Therapy

The evolutionary history of 2,658 cancers

Year:

Session type:

Theme:

Moritz Gerstung1
1European Bioinformatics Institute EMBL-EBI